Table 2.
Age Group | Pre* | Baseline* | LUM/IVA* | ||||
---|---|---|---|---|---|---|---|
−24 mo | −18 mo | −12 mo | −6 mo | 0 mo | 6 mo | 12 mo | |
Age ≥20 yr, kg/m2 (n = 17) | 21.9 ± 3.0 | 22.1 ± 2.8 | 22.2 ± 2.7 | 22.2 ± 2.7 | 21.9 ± 2.9 | 23.1 ± 2.6‡ | 23.1 ± 2.8§ |
Age <20 yr, z-score (n = 18) | −0.55 ± 1.2 | −0.42 ± 1.2 | −0.56 ± 1.2 | −0.35 ± 0.9 | −0.39 ± 1.1 | −0.18 ± 1.0‡ | −0.27 ± 1.1 |
Other†, kg/m2 (n = 4) | 22.9 ± 4.0 | 22.7 ± 4.3 | 22.4 ± 3.4 | 22.9 ± 3.8 | 22.5 ± 4.4 | 23.5 ± 4.4 | 23.5 ± 4.2 |
LUM/VIA, lumacaftor/ivacaftor
* Values are presented as mean ± SD.
† Patients who turned 20 years of age during the study period were not included in the analysis.
‡ p < 0.05 when compared with −24 months.
§ p < 0.01 when compared with −24 months.